Loading…
The use of dry amniotic membrane in pterygium surgery
Pterygium is a fibrovascular growth of the bulbar conjunctiva that crosses the limbus and extends over the peripheral cornea, in some cases resulting in significant visual morbidity. When treatment is indicated, surgery is necessary, and several management options exist. These include excision, conj...
Saved in:
Published in: | Clinical ophthalmology (Auckland, N.Z.) N.Z.), 2016-01, Vol.10 (Issue 1), p.705-712 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c615t-e1c29411ad90685ef316c18362a501fd80d4520489b372d54c4430ca7b1ba1033 |
---|---|
cites | |
container_end_page | 712 |
container_issue | Issue 1 |
container_start_page | 705 |
container_title | Clinical ophthalmology (Auckland, N.Z.) |
container_volume | 10 |
creator | Noureddin, Gelareh S Yeung, Sonia N |
description | Pterygium is a fibrovascular growth of the bulbar conjunctiva that crosses the limbus and extends over the peripheral cornea, in some cases resulting in significant visual morbidity. When treatment is indicated, surgery is necessary, and several management options exist. These include excision, conjunctival autografting, and the use of adjuvant therapies. This paper reviews the incidence and prevalence of pterygia and also describes the various techniques currently used to treat this condition. These management options are compared to the use of dry amniotic membrane grafting (AMG), specifically with regard to recurrence rates, time to recurrence, safety and tolerability, as well as patient factors including cosmesis and quality of life. AMG has been used in the treatment of ocular surface disease due to a variety of benefits, including its anti-inflammatory properties, as well as its ability to promote epithelial growth and suppress transforming growth factor-β signaling and fibroblast proliferation. However, rates of recurrence for AMG following pterygium excision still surpass other commonly used techniques, including conjunctival and limbal autografting. Nevertheless, there are circumstances in which AMG may be most beneficial to the patient, such as when preexisting conjunctival scarring is present, when the conjunctiva must be spared for future glaucoma filtering surgery, or in cases of large or double-headed pterygia. Therefore, surgeons should be prepared to offer this procedure as an option to their patients for the treatment of pterygia. |
doi_str_mv | 10.2147/OPTH.S80102 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c8a3b1d1e0894606810132945209a2fa</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A506621965</galeid><doaj_id>oai_doaj_org_article_c8a3b1d1e0894606810132945209a2fa</doaj_id><sourcerecordid>A506621965</sourcerecordid><originalsourceid>FETCH-LOGICAL-c615t-e1c29411ad90685ef316c18362a501fd80d4520489b372d54c4430ca7b1ba1033</originalsourceid><addsrcrecordid>eNptUl1rFDEUHUSxtfrkuwwIIsiuufnOS6EUtYVCBdfnkEkys1lmJmsyI-y_N-vWtSuSh1xuzj0n93Cq6jWgJQYqPt5_Xd0sv0kECD-pzgGEWDAqydNjzcVZ9SLnDUIcIymeV2dYACWSyvOKrda-nrOvY1u7tKvNMIY4BVsPfmiSGX0dxno7-bTrwjzUeU5dqV9Wz1rTZ__q4b6ovn_-tLq-Wdzdf7m9vrpbWA5sWniwWFEA4xTikvmWALcgCceGIWidRI4yjKhUDRHYMWopJcga0UBjABFyUd0eeF00G71NYTBpp6MJ-ncjpk6bVH7be22lIQ048EgqyoscICBFvfArg1tTuC4PXNu5GbyzfpyS6U9IT1_GsNZd_KmppEAUKwTvHwhS_DH7POkhZOv7vrgU56xBSIEkLxsU6Nt_oJs4p7FYpTHGrHivqPqL6kxZIIxtLLp2T6qvGOIcg-J72eV_UOU4PwQbR9-G0j8ZePdoYO1NP61z7OcpxDGfAj8cgDbFnJNvj2YA0vto6X209CFaBf3msX9H7J8skV_TVcQA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2225438949</pqid></control><display><type>article</type><title>The use of dry amniotic membrane in pterygium surgery</title><source>Taylor & Francis Open Access</source><source>PubMed Central</source><source>ProQuest Publicly Available Content database</source><creator>Noureddin, Gelareh S ; Yeung, Sonia N</creator><creatorcontrib>Noureddin, Gelareh S ; Yeung, Sonia N</creatorcontrib><description>Pterygium is a fibrovascular growth of the bulbar conjunctiva that crosses the limbus and extends over the peripheral cornea, in some cases resulting in significant visual morbidity. When treatment is indicated, surgery is necessary, and several management options exist. These include excision, conjunctival autografting, and the use of adjuvant therapies. This paper reviews the incidence and prevalence of pterygia and also describes the various techniques currently used to treat this condition. These management options are compared to the use of dry amniotic membrane grafting (AMG), specifically with regard to recurrence rates, time to recurrence, safety and tolerability, as well as patient factors including cosmesis and quality of life. AMG has been used in the treatment of ocular surface disease due to a variety of benefits, including its anti-inflammatory properties, as well as its ability to promote epithelial growth and suppress transforming growth factor-β signaling and fibroblast proliferation. However, rates of recurrence for AMG following pterygium excision still surpass other commonly used techniques, including conjunctival and limbal autografting. Nevertheless, there are circumstances in which AMG may be most beneficial to the patient, such as when preexisting conjunctival scarring is present, when the conjunctiva must be spared for future glaucoma filtering surgery, or in cases of large or double-headed pterygia. Therefore, surgeons should be prepared to offer this procedure as an option to their patients for the treatment of pterygia.</description><identifier>ISSN: 1177-5467</identifier><identifier>ISSN: 1177-5483</identifier><identifier>EISSN: 1177-5483</identifier><identifier>DOI: 10.2147/OPTH.S80102</identifier><identifier>PMID: 27143848</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>amniotic membrane ; Astigmatism ; conjunctival autograft ; Cornea ; Defects ; Ophthalmology ; pterygium ; Review ; Stem cells ; Studies ; Surgery ; Transplants & implants</subject><ispartof>Clinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10 (Issue 1), p.705-712</ispartof><rights>COPYRIGHT 2016 Dove Medical Press Limited</rights><rights>2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2016 Noureddin and Yeung. This work is published and licensed by Dove Medical Press Limited 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c615t-e1c29411ad90685ef316c18362a501fd80d4520489b372d54c4430ca7b1ba1033</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2225438949/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2225438949?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27143848$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Noureddin, Gelareh S</creatorcontrib><creatorcontrib>Yeung, Sonia N</creatorcontrib><title>The use of dry amniotic membrane in pterygium surgery</title><title>Clinical ophthalmology (Auckland, N.Z.)</title><addtitle>Clin Ophthalmol</addtitle><description>Pterygium is a fibrovascular growth of the bulbar conjunctiva that crosses the limbus and extends over the peripheral cornea, in some cases resulting in significant visual morbidity. When treatment is indicated, surgery is necessary, and several management options exist. These include excision, conjunctival autografting, and the use of adjuvant therapies. This paper reviews the incidence and prevalence of pterygia and also describes the various techniques currently used to treat this condition. These management options are compared to the use of dry amniotic membrane grafting (AMG), specifically with regard to recurrence rates, time to recurrence, safety and tolerability, as well as patient factors including cosmesis and quality of life. AMG has been used in the treatment of ocular surface disease due to a variety of benefits, including its anti-inflammatory properties, as well as its ability to promote epithelial growth and suppress transforming growth factor-β signaling and fibroblast proliferation. However, rates of recurrence for AMG following pterygium excision still surpass other commonly used techniques, including conjunctival and limbal autografting. Nevertheless, there are circumstances in which AMG may be most beneficial to the patient, such as when preexisting conjunctival scarring is present, when the conjunctiva must be spared for future glaucoma filtering surgery, or in cases of large or double-headed pterygia. Therefore, surgeons should be prepared to offer this procedure as an option to their patients for the treatment of pterygia.</description><subject>amniotic membrane</subject><subject>Astigmatism</subject><subject>conjunctival autograft</subject><subject>Cornea</subject><subject>Defects</subject><subject>Ophthalmology</subject><subject>pterygium</subject><subject>Review</subject><subject>Stem cells</subject><subject>Studies</subject><subject>Surgery</subject><subject>Transplants & implants</subject><issn>1177-5467</issn><issn>1177-5483</issn><issn>1177-5483</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUl1rFDEUHUSxtfrkuwwIIsiuufnOS6EUtYVCBdfnkEkys1lmJmsyI-y_N-vWtSuSh1xuzj0n93Cq6jWgJQYqPt5_Xd0sv0kECD-pzgGEWDAqydNjzcVZ9SLnDUIcIymeV2dYACWSyvOKrda-nrOvY1u7tKvNMIY4BVsPfmiSGX0dxno7-bTrwjzUeU5dqV9Wz1rTZ__q4b6ovn_-tLq-Wdzdf7m9vrpbWA5sWniwWFEA4xTikvmWALcgCceGIWidRI4yjKhUDRHYMWopJcga0UBjABFyUd0eeF00G71NYTBpp6MJ-ncjpk6bVH7be22lIQ048EgqyoscICBFvfArg1tTuC4PXNu5GbyzfpyS6U9IT1_GsNZd_KmppEAUKwTvHwhS_DH7POkhZOv7vrgU56xBSIEkLxsU6Nt_oJs4p7FYpTHGrHivqPqL6kxZIIxtLLp2T6qvGOIcg-J72eV_UOU4PwQbR9-G0j8ZePdoYO1NP61z7OcpxDGfAj8cgDbFnJNvj2YA0vto6X209CFaBf3msX9H7J8skV_TVcQA</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Noureddin, Gelareh S</creator><creator>Yeung, Sonia N</creator><general>Dove Medical Press Limited</general><general>Taylor & Francis Ltd</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20160101</creationdate><title>The use of dry amniotic membrane in pterygium surgery</title><author>Noureddin, Gelareh S ; Yeung, Sonia N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c615t-e1c29411ad90685ef316c18362a501fd80d4520489b372d54c4430ca7b1ba1033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>amniotic membrane</topic><topic>Astigmatism</topic><topic>conjunctival autograft</topic><topic>Cornea</topic><topic>Defects</topic><topic>Ophthalmology</topic><topic>pterygium</topic><topic>Review</topic><topic>Stem cells</topic><topic>Studies</topic><topic>Surgery</topic><topic>Transplants & implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Noureddin, Gelareh S</creatorcontrib><creatorcontrib>Yeung, Sonia N</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest Publicly Available Content database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Clinical ophthalmology (Auckland, N.Z.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Noureddin, Gelareh S</au><au>Yeung, Sonia N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The use of dry amniotic membrane in pterygium surgery</atitle><jtitle>Clinical ophthalmology (Auckland, N.Z.)</jtitle><addtitle>Clin Ophthalmol</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>10</volume><issue>Issue 1</issue><spage>705</spage><epage>712</epage><pages>705-712</pages><issn>1177-5467</issn><issn>1177-5483</issn><eissn>1177-5483</eissn><abstract>Pterygium is a fibrovascular growth of the bulbar conjunctiva that crosses the limbus and extends over the peripheral cornea, in some cases resulting in significant visual morbidity. When treatment is indicated, surgery is necessary, and several management options exist. These include excision, conjunctival autografting, and the use of adjuvant therapies. This paper reviews the incidence and prevalence of pterygia and also describes the various techniques currently used to treat this condition. These management options are compared to the use of dry amniotic membrane grafting (AMG), specifically with regard to recurrence rates, time to recurrence, safety and tolerability, as well as patient factors including cosmesis and quality of life. AMG has been used in the treatment of ocular surface disease due to a variety of benefits, including its anti-inflammatory properties, as well as its ability to promote epithelial growth and suppress transforming growth factor-β signaling and fibroblast proliferation. However, rates of recurrence for AMG following pterygium excision still surpass other commonly used techniques, including conjunctival and limbal autografting. Nevertheless, there are circumstances in which AMG may be most beneficial to the patient, such as when preexisting conjunctival scarring is present, when the conjunctiva must be spared for future glaucoma filtering surgery, or in cases of large or double-headed pterygia. Therefore, surgeons should be prepared to offer this procedure as an option to their patients for the treatment of pterygia.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>27143848</pmid><doi>10.2147/OPTH.S80102</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1177-5467 |
ispartof | Clinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10 (Issue 1), p.705-712 |
issn | 1177-5467 1177-5483 1177-5483 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_c8a3b1d1e0894606810132945209a2fa |
source | Taylor & Francis Open Access; PubMed Central; ProQuest Publicly Available Content database |
subjects | amniotic membrane Astigmatism conjunctival autograft Cornea Defects Ophthalmology pterygium Review Stem cells Studies Surgery Transplants & implants |
title | The use of dry amniotic membrane in pterygium surgery |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A14%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20use%20of%20dry%20amniotic%20membrane%20in%20pterygium%20surgery&rft.jtitle=Clinical%20ophthalmology%20(Auckland,%20N.Z.)&rft.au=Noureddin,%20Gelareh%20S&rft.date=2016-01-01&rft.volume=10&rft.issue=Issue%201&rft.spage=705&rft.epage=712&rft.pages=705-712&rft.issn=1177-5467&rft.eissn=1177-5483&rft_id=info:doi/10.2147/OPTH.S80102&rft_dat=%3Cgale_doaj_%3EA506621965%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c615t-e1c29411ad90685ef316c18362a501fd80d4520489b372d54c4430ca7b1ba1033%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2225438949&rft_id=info:pmid/27143848&rft_galeid=A506621965&rfr_iscdi=true |